Progenity to present at three key investor conferences
Presenting at the BTIG, Raymond James, and Cowen health care conferences.
SAN DIEGO, February 26, 2019 – Progenity, Inc., a privately held biotechnology company developing precision medicine solutions across genomic/epigenomic, proteomic, and microbiomic diagnostic and therapeutic platforms, announced today that Harry Stylli, Ph.D., CEO, will be participating in several upcoming investor conferences.
The BTIG MedTech, Life Science and Diagnostic Tools Conference is being held February 27-28 in Snowbird, Utah. Dr. Stylli will host one-on-one-meetings with investors on Thursday, February 28.
The Raymond James 40th Annual Institutional Investors Conference is March 3-6 in Orlando, Florida. Progenity will present a corporate overview on Monday, March 4 from 4:00 PM to 4:30 PM, and will host a breakout session immediately following the presentation from 4:35 PM to 5:05 PM. Dr. Stylli will also participate in one-on-one meetings with investors.
The Cowen 39th Annual Health Care Conference will be held March 11-13 in Boston, Massachusetts. Progenity will present a corporate overview on Tuesday, March 12 from 12:00 PM to 12:35 PM. Company leadership will also participate in one-on-one meetings with investors during the conference.
Read more news.
